Showing results (231-240 of 432) with videos related to

Sort By:
Pageof 44
The Journal of Antimicrobial Chemotherapy|December 25, 2014
Atherogenic properties of lipoproteins in HIV patients starting atazanavir/ritonavir or darunavir/ritonavir: a substudy of the ATADAR randomized studyMaria Saumoy, Jordi Ordóñez-Llanos, Esteban Martínez, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 2012
Simplification to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patientsJoaquin Burgos, Manuel Crespo, Vicenç Falcó, et al.
Antiviral Therapy|May 11, 2011
Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN TrialVicente Soriano, Keikawus Arastéh, Horacio Migrone, et al.
Brain and Behavior|February 9, 2022
Neuropsychological deficits in patients with cognitive complaints after COVID-19Carmen García-Sánchez, Marco Calabria, Nicholas Grunden, et al.
The Journal of Antimicrobial Chemotherapy|August 13, 2016
Improved adipose tissue function with initiation of protease inhibitor-only ARTRobert T Maughan, Eoin R Feeney, Emilie Capel, et al.
The Journal of Antimicrobial Chemotherapy|March 21, 2012
Mutations in the protease gene associated with virological failure to lopinavir/ritonavir-containing regimensJosé R Santos, Josep M Llibre, Arkaitz Imaz, et al.
HIV Clinical Trials|April 16, 2015
Cardiovascular risk factors and lifetime risk estimation in HIV-infected patients under antiretroviral treatment in SpainVicente Estrada, José Ignacio Bernardino, Mar Masiá, et al.
AIDS (London, England)|August 10, 2012
Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNAEoin R Feeney, Marit G A van Vonderen, Ferdinand Wit, et al.
The Journal of Antimicrobial Chemotherapy|August 31, 2021
Early antiretroviral therapy initiation effect on metabolic profile in vertically HIV-1-infected childrenLaura Tarancón-Diez, Anna Rull, Pol Herrero, et al.
Scientific Reports|February 21, 2020
New signatures of poor CD4 cell recovery after suppressive antiretroviral therapy in HIV-1-infected individuals: involvement of miR-192, IL-6, sCD14 and miR-144Francisco Hernández-Walias, María J Ruiz-de-León, Isaac Rosado-Sánchez, et al.
Pageof 44